AI in Medical Imaging Market Size & Growth Forecast 2027–2036, By Segments (Technology, End Use, Modalities, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
AI in Medical Imaging Market size stood at USD 2.5 billion in 2026 and is predicted to grow at a 33.35% CAGR from 2027 to 2036, attaining USD 44.45 billion by 2036. The industry revenue for 2027 is estimated at USD 3.2 billion.
Get more details on this report
Request Free Sample ReportAI in Medical Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 45.58% share due to advanced healthcare IT systems, strong imaging infrastructure, and early integration of AI into diagnostic workflows.
- Asia Pacific is expanding at 37.18% CAGR, driven by healthcare modernization, rising imaging demand, and increasing use of AI to improve diagnostic efficiency and access.
Segment Momentum
- Deep Learning held a 60.55% share in 2026, driven by its strong fit with image analysis workflows, including pattern recognition, anomaly detection, and automated diagnostic interpretation.
- NLP is expanding rapidly because it improves the use of radiology reports, physician notes, and diagnostic documentation, helping integrate imaging insights into broader clinical workflows and decision-making processes.
Market Expansion Drivers
- Rising demand for early and accurate diagnostics accelerating AI-powered imaging solution adoption.
- Growing imaging data volumes increasing deployment of deep learning-based radiology workflows.
- Expanding telemedicine infrastructure driving cloud-integrated remote imaging and clinical decision support platforms.
Leading Market Participants
- Major players in the AI in medical imaging market include GE HealthCare (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Microsoft Corporation (United States), Tempus Labs, Inc. (United States), Viz.ai, Inc. (United States), HeartFlow, Inc. (United States), Butterfly Network, Inc. (United States), Aidoc Medical Ltd. (Israel).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.5 billion
- 2027 Estimated Market Size: USD 3.2 billion.
- Projected Market Size: USD 44.45 billion by 2036
- Growth Forecast: 33.35% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Deep Learning (Technology) | Hospitals (End Use) | CT Scan (Modalities) | Neurology (Application)
- Emerging Opportunity Segment: Natural Language Processing (NLP) (Technology) | Hospitals (End Use) | X-rays (Modalities) | Breast Screening (Application)
Market Growth Drivers and Industry Trends
Rising demand for early and accurate diagnostics accelerating AI-powered imaging solution adoption
The need for faster and more accurate disease detection is driving the AI in medical imaging market as healthcare providers seek technologies that can support clinicians in identifying abnormalities at earlier stages. AI-powered imaging solutions can analyze medical images efficiently, assist with the detection of subtle findings, and support radiologists in prioritizing cases that require closer evaluation. By improving image interpretation workflows and providing additional clinical insights, these technologies can support more consistent diagnostic decision-making across radiology and other imaging-intensive specialties.
Growing imaging data volumes increasing deployment of deep learning-based radiology workflows
Rapid growth in medical imaging data is creating a strong use case for the AI in medical imaging market, particularly through deep learning systems capable of processing large volumes of complex image information. Hospitals and diagnostic facilities generate extensive datasets across modalities such as MRI, CT, ultrasound, and X-ray, creating challenges in manual review and workflow management. Deep learning tools can help automate image analysis, identify relevant patterns, and organize cases for radiologists, allowing imaging departments to manage growing workloads while maintaining structured diagnostic processes.
Expanding telemedicine infrastructure driving cloud-integrated remote imaging and clinical decision support platforms
The expansion of telemedicine infrastructure is opening new opportunities for the AI in medical imaging market by enabling imaging data to be accessed and analyzed across geographically distributed healthcare settings. Cloud-integrated platforms can facilitate secure sharing of medical images, support remote radiology workflows, and provide AI-assisted clinical decision support to healthcare professionals outside centralized facilities. This integration is particularly useful where specialist imaging expertise is limited, as AI tools can assist remote interpretation and help healthcare providers incorporate imaging insights into broader virtual care workflows.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for early and accurate diagnostics accelerating AI-powered imaging solution adoption | 2.40% | High | North America, Asia Pacific | High | Near Term |
| Growing imaging data volumes increasing deployment of deep learning-based radiology workflows | 2.10% | Moderate | North America, Europe | High | Mid Term |
| Expanding telemedicine infrastructure driving cloud-integrated remote imaging and clinical decision support platforms | 1.80% | High | Asia Pacific, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the AI in medical imaging market, holding a 45.58% share in 2026, supported by advanced healthcare infrastructure, strong adoption of digital diagnostic technologies, and substantial investment in artificial intelligence across clinical workflows. The region benefits from widespread availability of sophisticated imaging systems, growing demand for faster and more accurate diagnosis, and a favorable environment for healthcare technology innovation. Increasing integration of AI into radiology, image interpretation, workflow automation, and clinical decision support is further strengthening regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to be the fastest-growing region, driven by expanding healthcare infrastructure, rising adoption of advanced medical technologies, and increasing efforts to improve diagnostic capacity across emerging healthcare systems. Growing patient volumes, greater awareness of early disease detection, and investments in hospital modernization are creating favorable conditions for AI-enabled imaging solutions. The increasing digitalization of healthcare services and focus on improving diagnostic efficiency are also supporting broader adoption across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Imaging AdoptionGermany emphasizes AI solutions that complement high-quality diagnostic imaging and support standardized clinical decision-making. Hospitals and imaging centers increasingly evaluate platforms that integrate with digital health initiatives while maintaining strong requirements for data quality and regulatory compliance.
France 🇫🇷
Hospital AI DeploymentFrance focuses on deploying AI imaging applications across hospital networks to improve diagnostic accuracy and optimize resource utilization. French healthcare institutions prioritize clinically validated solutions that align with national digital health strategies and support multidisciplinary care delivery.
Italy 🇮🇹
Diagnostic ModernizationItaly strengthens adoption of AI-assisted medical imaging by modernizing diagnostic capabilities across regional healthcare systems. Italian providers increasingly seek scalable imaging software that enhances reporting efficiency, supports clinical collaboration, and integrates with existing radiology infrastructure.
Japan 🇯🇵
Workflow Optimization FocusJapan adopts AI in medical imaging to address growing diagnostic workloads and improve operational efficiency across healthcare facilities. Japanese providers increasingly deploy AI-assisted image analysis to support radiologists while ensuring compatibility with advanced imaging equipment and clinical workflows.
South Korea 🇰🇷
Digital Imaging InnovationSouth Korea advances AI in medical imaging through digitally connected healthcare environments and rapid technology implementation. Healthcare organizations increasingly adopt AI-enabled imaging software that enhances diagnostic consistency, supports early disease detection, and integrates with smart hospital initiatives.
United States 🇺🇸
Clinical AI IntegrationThe U.S. continues to prioritize AI-enabled imaging platforms that improve diagnostic workflows, radiology efficiency, and clinical decision support. Healthcare providers increasingly focus on integrating validated AI applications into existing imaging infrastructure while addressing regulatory, interoperability, and reimbursement considerations.
Segment Leadership and Growth Trends
AI in Medical Imaging Market Share (%), by Technology, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportTechnology Segment Analysis: Deep Learning (Largest Segment) vs Natural Language Processing (NLP) (Fastest-Growing Segment)
Deep learning accounted for a 60.55% share in 2026, establishing the technology as the leading segment in the AI in medical imaging market. Its strong position is supported by the ability of deep learning models to analyze complex medical images and identify patterns associated with abnormalities, lesions, and other clinically relevant findings. These capabilities can assist radiologists and other healthcare professionals with image interpretation, workflow prioritization, and diagnostic decision support. Increasing adoption of AI-assisted imaging and the growing volume of medical images generated across healthcare systems are further strengthening demand for deep learning technologies.
Natural language processing (NLP) is expected to be the fastest-growing segment as healthcare providers increasingly seek to connect medical imaging insights with unstructured clinical information. NLP can help process radiology reports, patient histories, clinical notes, and other textual records, enabling more comprehensive interpretation of imaging findings within the broader clinical context. The increasing integration of imaging workflows with electronic health records and the demand for automated documentation, information extraction, and clinical decision support are creating significant opportunities for NLP-based applications.
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals dominated the AI in medical imaging market with a 55.27% share in 2026 and are also expected to remain the fastest-growing end-use segment. The segment's strong position stems from the extensive use of medical imaging across hospital departments, including radiology, oncology, cardiology, emergency care, and other specialized clinical settings. Hospitals generate substantial volumes of diagnostic images and increasingly require tools that can support faster interpretation, workflow optimization, and consistent clinical decision-making. The expanding integration of artificial intelligence into hospital imaging infrastructure, combined with the need to manage growing diagnostic workloads and improve operational efficiency, continues to reinforce hospitals as the leading adoption environment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Technology | Deep Learning, Natural Language Processing (NLP), Other | Deep Learning | Natural Language Processing (NLP) |
| End Use | Hospitals, Diagnostic Imaging Centers, Others | Hospitals | Hospitals |
| Modalities | CT Scan, MRI, X-rays, Ultrasound, Nuclear Imaging | CT Scan | X-rays |
| Application | Neurology, Respiratory and Pulmonary, Cardiology, Breast Screening, Orthopedics, Others | Neurology | Breast Screening |
Competitive Landscape and Market Positioning
Prominent players in the AI in medical imaging market:
1. GE HealthCare (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Microsoft Corporation (United States)
6. Tempus Labs Inc. (United States)
7. Viz.ai Inc. (United States)
8. HeartFlow Inc. (United States)
9. Butterfly Network Inc. (United States)
10. Aidoc Medical Ltd. (Israel)
Continuous advancements in deep learning algorithms and image interpretation tools are intensifying innovation across the AI in medical imaging market. Market participants are enhancing diagnostic accuracy through automated detection systems capable of supporting radiology workflows and clinical decision-making. Increasing deployment of cloud-enabled imaging platforms and predictive analytics solutions is further improving scalability, while ongoing research initiatives continue to expand the application scope of AI-assisted diagnostics.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Canon Medical Systems Corporation (Japan) | |||||||
| Microsoft Corporation (United States) | |||||||
| Tempus Labs Inc. (United States) | |||||||
| Viz.ai Inc. (United States) | |||||||
| HeartFlow Inc. (United States) | |||||||
| Butterfly Network Inc. (United States) | |||||||
| Aidoc Medical Ltd. (Israel). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Aidoc | Jan-26 | Aidoc secured U.S. FDA clearance for its comprehensive, CARE foundation model-driven triage solution for abdominal CT scans. The single-workflow solution integrates 11 newly cleared acute indications with three existing ones, shifting clinical radiology operations away from first-in, first-out queues toward prioritized, medical necessity-based triage. |
| Philips | Dec-25 | Philips entered a definitive agreement to acquire SpectraWave, an innovator in AI-infused intravascular imaging and coronary physiology. The acquisition expands Philips' image-guided therapy device portfolio by integrating advanced optical coherence tomography and AI-enabled fractional flow reserve calculations into its global interventional platform. |
| HOPPR | Nov-25 | HOPPR launched its AI Foundry developer platform, a specialized environment optimized for building, fine-tuning, and validating multi-modal medical imaging AI models. The platform incorporates quality management system architectures to accelerate regulatory compliance and simplify the commercialization of clinical radiology algorithms. |
| Philips and NVIDIA | May-25 | Philips partnered with NVIDIA to develop a foundational generative AI architecture for magnetic resonance imaging technology. The partnership leverages deep learning to optimize image reconstruction, drastically cut patient scan times, and eliminate operational bottlenecks in standard clinical radiology workflows. |
| Microsoft | Mar-25 | Microsoft expanded its portfolio of healthcare-specific generative AI infrastructure by introducing fine-tuning features for MedImageInsight. The multimodal foundational model covers 14 distinct medical imaging categories, alongside CXRReportGen, a specialized deep learning tool designed for automated radiology image-to-report generation. |
| Harrison.ai | Feb-25 | Harrison.ai raised $112 million in a Series C funding round to expand its AI-backed diagnostic imaging and automated clinical workflow solutions, with a particular focus on scaling enterprise deployment across the U.S. healthcare sector. |
| Coreline Soft | Feb-25 | Coreline Soft obtained U.S. FDA 510(k) clearance for its upgraded AVIEW CAC software, an AI-driven coronary calcium analysis platform. The regulatory approval expands validated clinical use cases for automated coronary artery calcification assessments, strengthening the firm's position in cardiovascular imaging diagnostics. |
| Sutter Health and GE HealthCare | Jan-25 | Sutter Health and GE HealthCare launched a seven-year strategic Care Alliance to roll out advanced AI-powered imaging across Sutter’s California provider network. The large-scale deployment integrates intelligent algorithms across PET/CT, MRI, X-ray, and ultrasound modalities to shorten diagnostic turnaround times and improve disease detection. |
| GE HealthCare | Nov-24 | GE HealthCare entered an operational partnership with DeepHealth, a subsidiary of RadNet, to commercialize and scale AI-driven radiology applications. The initiative focuses on embedding machine learning capabilities directly into front-line diagnostic imaging hardware to maximize clinical reporting throughput. |
| GE HealthCare | Jan-24 | GE HealthCare finalized an acquisition agreement to buy MIM Software, a provider of medical imaging analysis and digital workflow software. The transaction integrates specialized imaging analytics across molecular radiotherapy, diagnostic imaging, and radiation oncology to bolster GE HealthCare's multi-modality digital health ecosystem. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
AI in Medical Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Imaging Workflow Stage | Image Acquisition, Image Reconstruction & Enhancement, Image Analysis & Detection, Clinical Interpretation & Reporting |
| AI Solution Type | AI-Assisted Detection, AI-Assisted Diagnosis, Image Quantification & Measurement, Workflow Optimization & Triage |
| Procurement Model | Direct Purchase, Subscription-Based Software, Software-as-a-Service, Managed AI Services |
AI in Medical Imaging Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Clinical AI Adoption Readiness Assessment |
|
| Imaging Workflow Automation Opportunity Analysis |
|
| AI Validation and Real-World Evidence Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow big is the AI in medical imaging market?
What is the anticipated CAGR of the AI in medical imaging industry?
How are clinical workflow priorities accelerating AI adoption in medical imaging?
Why are imaging volume growth and telemedicine expansion driving investment in AI-enabled imaging platforms?
Which technology segment leads the AI in medical imaging market?
Why is Natural Language Processing (NLP) the fastest-growing technology segment in AI medical imaging?
Why does North America lead the AI in medical imaging market?
How is Asia Pacific driving AI adoption in medical imaging?
Who are the major participants shaping the AI in medical imaging landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization